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Abstract
Background: A compact passive oxide layer can grow on tantalum (Ta). It has been reported that this oxide layer
can facilitate bone ingrowth in vivo though the development of bone-like apatite, which promotes hard and soft
tissue adhesion. Thus, Ta surface treatment on facial implant materials may improve the tissue response, which
could result in less fibrotic encapsulation and make the implant more stable on the bone surface. The purposes of
this study were to verify whether surface treatment of facial implant materials using Ta can improve the
biohistobiological response and to determine the possibility of potential clinical applications.
Methods: Two different and commonly used implant materials, silicone and expanded polytetrafluoroethylene
(ePTFE), were treated via Ta ion implantation using a Ta sputtering gun. Ta-treated samples were compared with
untreated samples using in vitro and in vivo evaluations. Osteoblast (MG-63) and fibroblast (NIH3T3) cell viability
with the Ta-treated implant material was assessed, and the tissue response was observed by placing the implants
over the rat calvarium (n = 48) for two different lengths of time. Foreign body and inflammatory reactions were
observed, and soft tissue thickness between the calvarium and the implant as well as the bone response was
measured.
Results: The treatment of facial implant materials using Ta showed a tendency toward increased fibroblast and
osteoblast viability, although this result was not statistically significant. During the in vivo study, both Ta-treated and
untreated implants showed similar foreign body reactions. However, the Ta-treated implant materials (silicone and
ePTFE) showed a tendency toward better histological features: lower soft tissue thickness between the implant and
the underlying calvarium as well as an increase in new bone activity.
Conclusion: Ta surface treatment using ion implantation on silicone and ePTFE facial implant materials showed the
possibility of reducing soft tissue intervention between the calvarium and the implant to make the implant more
stable on the bone surface. Although no statistically significant improvement was observed, Ta treatment revealed
a tendency toward an improved biohistological response of silicone and ePTFE facial implants. Conclusively,
tantalum treatment is beneficial and has the potential for clinical applications.
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Background
Facial augmentation procedures are some of the most
commonly performed cosmetic procedures [1]. Silicone
rubber and silicone rubber-based materials are widely
used in facial cosmetics. This has been the case for many
years. However, there is increasing evidence suggesting
that the intrinsically hydrophobic nature of the silicone
rubber surface leads to poor cell adhesion and tissue
compatibility between the implant and surrounding tis-
sues, which results in capsule formation and gradual
thickening and contracture of these tissues [2, 3]. In
addition, these capsular voids encourage bacterial infec-
tion and invasion as well as inflammation during long-
term use.
ePTFE, which is a polymer that was invented by W.L.
Gore Company and has been safely used as facial im-
plant material with several clinical applications for more
than 10 years, if necessary, is relatively easy to remove
[4]. However, an unsatisfactory appearance may result
from the implant folding on itself due to the mobility of
the underlying tissues. Therefore, the major disadvan-
tages of using facial implants continue to be susceptibil-
ity to infection and possible displacement. Thus, there is
a need for further research into ways to improve the
outcome of facial implant use. Surface modification of
implant materials is a commonly used method to im-
prove the biocompatibility of implant materials and to
overcome the abovementioned disadvantages. Various
materials have been used as implant coatings.
Tantalum has been receiving increasing interest as a
biomaterial due to its excellent biocompatibility (e.g.,
outstanding bone-like apatite forming capability, absence
of cytotoxic ion release or dissolution in local, systemic,
and remote organs, and good osseointegration), superior
strength, and anti-corrosion properties [5]. Tantalum is
a corrosion-resistant transition metal element with
atomic number 73. It is a promising metallic material, at
least in terms of bioperformance. It has been used in the
medical field since the 1940s when Burke used pure tan-
talum in several cases, such as in the skin, in the sub-
cutaneous and tendon sutures, and in several plates [6].
Tantalum has the ability to form a compact, passive, ex-
tremely thin, and transparent but strong and tenacious
oxide layer that strongly adheres to tantalum. This oxide
layer has the capacity to facilitate bone ingrowth under
in vivo conditions via the development of bone-like
apatite that promotes hard and soft tissue adhesion [7].
Furthermore, Ta is a hard, ductile, and highly chemical-
resistant material with good apposition to human bone.
In addition, the mechanical properties of tantalum are
impressive. The metal is comparable to steel in its
strength, toughness, and workability [8, 9]. The aim of
this study was (1) to verify whether the use of tantalum
as a surface treatment material for facial implant
materials can improve the biohistobiological features




A 0.85-mm-thick ePTFE membrane (Meari Co., Ltd.,
Gyeonggi-do, Republic of Korea) and a 1-mm-thick sili-
cone rubber consisting of clinical-grade silicone (Bistool
Co. Ltd., Seoul, Republic of Korea) with dimensions of
10 × 10mm was prepared for the experimental evalu-
ation. All samples were ultrasonically cleaned in alcohol
and deionized water for 5 min before processing with
tantalum (Ta) coating. A Ta target (diameter 75 mm,
thickness 5 mm, purity 99.99%, Kojundo Korea Co., Ltd.,
Gyeonggi-do, Republic of Korea) was placed in a DC
magnetron sputter gun housing (Ultech Co. Ltd., Daegu,
Korea). The vacuum chamber was pumped to 5 × 10−4
Pa using rotary and diffusion pumps. To generate a suf-
ficient amount of Ta ions and neutral atoms, 25W of
target power was applied to the Ta sputtering gun, and a
working pressure and temperature were maintained at
0.6 Pa and 25 °C, respectively, during the process. The
samples were placed on a stainless steel plate parallel to
the Ta target surface at a 100-mm distance. Ta ions and
neutral atoms were implanted into the sample surfaces
for 3 min using a high negative bias of 2000 V. For com-
parative purposes, only untreated ePTFE and untreated
silicone rubber sheets were used for the control group.
Thus, all of the samples in this study were divided into
the following four groups: Ta-treated silicone implant
(G1), untreated silicone implant (G2), Ta-treated ePTFE
implant (G3), and untreated ePTFE implant (G4).
TEM and SEM observation
To observe the Ta-implanted regions on the implant
surfaces, high-resolution transmission electron micro-
scope images were collected using transmission electron
microscopy (TEM) (JEM-2100F, JEOL, Japan) operated
at 200 kV. The cross-sectional image of the Ta-coated
implant surface was prepared and obtained using fo-
cused ion beam milling and field-emission scanning
electron microscopy (FIB/FE-SEM) (AURIGA, Carl
Zeiss, Germany). Prior to the milling process, protective
layers containing platinum and carbon were coated onto
the implant surfaces.
Cell viability
To evaluate the viability of osteoblasts (MG-63) and
fibroblasts (NIH3T3), an EZ-Cytox assay (Daeil Lab
Service Co. Std., Seoul, Korea) was performed according
to the manufacturer’s protocol. MG-63 and NIH3T3
cells were plated at a density of 3 × 104 cells/mL on
the implant materials and cultured in Dulbecco’s
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modified Eagle’s medium (DMEM, ATCC 30-2003)
(Life Technologies Co., Grand Island, NY, USA) and
Eagle’s minimum essential medium (EMEM, Gibco
11995) (Life Technologies Co.) with 10% fetal bovine
serum (FBS) containing 1% penicillin/streptomycin at
37 °C under 5% CO2 in a humidified atmosphere. Im-
plants were conditioned in a medium for 5 h before
insertion into 24-well cell culture plates. After cultur-
ing for 24, 48, or 72 h, the culture medium was dis-
carded, and the samples were washed three times
with phosphate-buffered saline (PBS) and then incu-
bated at 37 °C for another 4 h in fresh culture
medium containing 10 μL of EZ-Cytox solution. To
investigate the effects of the tantalum-treated or un-
treated silicone or ePTFE surface on the viability of
MG-63 and NIH3T3, the absorbance values of each
cell culture were measured by using a spectrophotom-
eter (BioTek Instruments, Inc., Winooski, VT, USA)
at 490 nm. Each test was repeated four times (n = 6).
Animal study
For biohistological evaluation, an animal experiment was
conducted. All experimental surgical procedures were
performed in a specific pathogen-free unit. The animals,
6-week-old male healthy Sprague-Dawley rats, were kept
in a room with a 12-h light/dark cycle and temperature
that varied between 23 and 25 °C. Furthermore, the ani-
mals were housed in soft, sterile bedding that was free
from antibacterial products. The animals had open ac-
cess to food and sterile non-acidic water.
The rats were randomly assigned to one of the follow-
ing groups:
G1 (n = 6): tantalum-treated silicone implant
G2 (n = 6): untreated silicone implant
G3 (n = 6): tantalum-treated ePTFE implant
G4 (n = 6): untreated ePTFE implant
The experiment was conducted over two time inter-
vals: 4 and 8 weeks for the silicone implant material and
2 and 4 weeks for the ePTFE implant material. The ani-
mals were anesthetized using a ketamine/xylazine mix-
ture (75–100mg/kg ketamine + 5–10 mg/kg xylazine),
which was administered intraperitoneally (IP) using a
maximum dose of 10 mL/kg. The incision site, which
was located behind the lambdoid suture, was shaved and
painted using iodine swabs. An approximately 2-cm-
long incision was made behind the lambdoid suture
through the skin, subcutaneous tissue, deep fascia, and
periosteum up to the calvarial bone. The soft tissue over
the skull bone was reflected, and the implants were
inserted into all animals in all four groups (Fig. 1). Skin
apposition was achieved using subcutaneous sutures
made from 4-0 Vicryl (Ethicon, Livingston, UK).
Histological evaluation
At the completion of the study, the rats were sacrificed
using an overdose of an intraperitoneal ketamine/xyla-
zine mixture. Histological samples, including implants
and the surrounding tissues, were obtained carefully to
prevent implant movement. The samples were fixed in
buffered formalin for 24 h, dehydrated, and embedded in
paraffin wax. Tissue sections were mounted on glass
slides and stained with hematoxylin and eosin (H&E) for
histopathological evaluation. Images were captured using
a specialized system, SPOT RTTM-KE color mosaic, and
digitized via SPOT software version 4.6 (Diagnostic
Instruments, Inc., Sterling Heights, MI, USA). For sim-
plicity, images were studied at × 400 magnification. The
soft tissue thickness between the implants and the bone,
the extent of new bone formation, and the severity of
the inflammatory reaction were measured and analyzed.
The sections were processed, placed on slides, and
stained with hematoxylin and eosin stain. Histological
evaluation was performed on each section to evaluate
the inflammation, foreign body reaction, amount of soft
tissue filling the gap between the implants and the cal-
varial bone, and newly formed bone along the superficial
layer of the calvarium toward the implants. The inflam-
mation and foreign body reaction were blindly evaluated
by a board-certified pathologist. According to the
method of Pinese et al., soft tissue measurements were
Fig. 1 Intraoperative photograph. Intraoperative photograph
showing the implant material adapted to the calvarium before
suturing. The rat’s head was shaved and disinfected prior to making
an incision. A 2-cm-long transverse incision was made on the rat’s
calvarium. Then, the implant was placed subperiosteally over
the calvaria
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taken at 13 random regions along the implant-bone gap
and then averaged to compare Ta-treated and untreated
implants [10]. To evaluate the newly formed bone, histo-
logical evaluation of the slides was conducted. The newly
formed bone was evaluated and scored according to its
quantity. The following scores were assigned, as appro-
priate: no bone (score = 0), little stumps of bone (score =
1), moderate bone with gaps (score = 2), and complete
bone along the calvarium surface (score = 3) [11].
Statistical analysis
All data are expressed as the mean ± standard deviation
(SD). Data analysis was conducted using the SPSS
Statistics software ver. 25 (IBM, Armonk, NY, USA).
Nonparametric data comparisons were performed using
the Wilcoxon-Mann-Whitney U test. Statistical signifi-
cance was set at p < 0.05.
Results
Tantalum ion implantation
After surface modification via Ta ion implantation, the
Ta element was observed on the surface of the implant
materials. In the TEM cross-sectional images (Fig. 2), a
Ta-implanted region with a 20~30-nm thickness was
clearly detected between the surfaces of the implants
and the protective carbon coating layer.
Cell viability
The mean absorbance value at a wavelength of 450 nm
for the Ta-treated silicone implant materials was
0.060 ± 0.013, and for the untreated silicone implants,
the value was 0.054 ± 0.040. The OD value was higher
for the Ta-treated silicone implant material; however,
the result was not statistically significant (p value = 0.4).
The ODs for Ta-treated silicone and untreated silicone
were 0.089 ± 0.034 and 0.062 ± 0.023, respectively, with a
p value = 0.4. The result was better than that for un-
treated silicone, but not statistically significant (Table 1).
The optical density was used to measure the cell via-
bility of fibroblasts and osteoblasts at a wavelength of
450 nm. For Ta-treated silicone implant materials, the
OD (0.060 ± 0.013) was higher than that of untreated
silicone implant materials (0.054 ± 0.008) (p = 0.4). In the
case of Ta-treated ePTFE, the tantalum-treated implants
showed results (0.089 ± 0.034) that were comparable
with the untreated implants (0.062 ± 0.023), p value =
0.4. The results were not statistically significant. In the
case of osteoblast viability, even though the OD mea-
surements were higher for the Ta-treated implant mate-
rials compared with untreated materials, the results were
not statistically significant.
Histological evaluation
All animals recovered uneventfully after the implant-
ation. There were no cases of death, swelling, or pus dis-
charge at the implant sites in any of the animals during
the study period. According to a report by a pathologist,
macrophages and gain cells were observed in a short-
term experiment. However, in a long-term experiment,
none of these cells were observed (Fig. 3). The soft tissue
filling the gap between the implant and the calvarium
bone was evaluated in all specimens, and the mean ±
standard deviation (SD) was recorded. Comparisons
were performed using the Wilcoxon-Mann-Whitney U
test. For short-term Ta-treated silicone implants, the
mean soft tissue thickness was 73 ± 34 μm, while the
mean thickness for the untreated silicone implant was
92 ± 43 μm. There was less soft tissue filling the gap
Fig. 2 Transmission and scanning electron microscopy images of a tantalum implanted ePTFE implant material. A Transmission electron
microscopy images: (a) A protective carbonic layer was formed on the implant material surface after treatment with Ta. (b) Ta layer after
implantation. (c) ePTFE implant material. B Scanning electron microscope images: long two-headed arrows, protective carbonic layer. Short two-
headed arrow, Ta layer after ion implantation. (d) ePTFE implant material
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from the Ta-treated implant material; however, the re-
sult was not statistically significant (p value = 0.7). In the
long-term experiment of silicone implant materials, the
Ta-treated implant showed better results compared with
untreated implants (Ta-treated 82 ± 27 μm and untreated
115 ± 0.24 μm). However, this result was not statistically
significant (p value = 0.3). In the case of the newly
formed bone in the short-term silicone implant material,
we did not observe any newly formed bone from either
the Ta-treated silicone implants or the untreated silicone
implant materials. In the long-term experiment, a similar
amount of newly formed bone was observed in the Ta-
treated and untreated silicone implants (0.20 ± 0.45 μm,
p value = 1.00). Ta coatings did not show a significant
improvement compared with the untreated surface
(Table 2).
Thickness of the soft tissue was expressed as microme-
ters with the mean and SD reported. In the case of the
Ta-treated implant, the thickness was 73 ± 34 μm, while
in the untreated group, the thickness was 92 ± 43. The
difference was not statistically significant. The p value
was equal to 0.7. In the long-term study, the p value was
0.3, which was not statistically significant. New bone for-
mation in the silicone implant material showed similar
results in the short term, with no new bone formation.
In the long-term experiment, new bone was observed,
and the mean ± SD was almost the same between the
Table 1 Cell viability assessment
Mean ± SD p value Mean ± SD p value
Group Fibroblast Osteoblast
Ta-treated silicone 0.060 ± 0.013 0.4 0.173 ± 0.101 0.7
Untreated silicone 0.054 ± 0.008 0.128 ± 0.070
Ta-treated ePTFE 0.089 ± 0.034 0.4 0.349 ± 0.285 0.7
Untreated ePTFE 0.062 ± 0.023 0.202 ± 0.081
Fig. 3 Photomicrographs of the histological slides. Photomicrographs of the histological slides showing biological responses toward Ta-treated
and untreated facial implants. a Untreated silicone implant material and b Ta-treated silicone implant material. The two-headed arrows in a and b
indicate the soft tissue thickness between the implant material and the bone at 8-week intervals. c Untreated ePTFE implant and d treated ePTFE
implant material. The upwards filled arrows in c and d indicate newly formed bone between the implant material and the bone at 4-week
intervals (H&E stain, × 400)
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Ta-treated and untreated silicone implant material
(0.20 ± 0.45).
In the case of the ePTFE implant materials, in the Ta-
treated group, the mean soft tissue thickness was 95 ±
71 μm, while the mean thickness for the untreated
ePTFE implant was 111 ± 70 μm in the short-term ex-
periment. There was less soft tissue filling the gap in the
case of the Ta-treated implant material; however, the re-
sult was not statistically significant (p value = 0.6). In the
long-term experiment of the ePTFE implant materials,
the Ta-treated implant did not show any statistically sig-
nificant differences. For the Ta-treated material, the
mean soft tissue thickness was 38 ± 17 μm, and for the
untreated implants, the mean soft tissue thickness was
70 ± 63 μm (p value = 0.7). In the case of the newly
formed bone evaluation, in the short-term experiment,
the newly formed bone score was 0.60 ± 0.55 for the Ta-
treated implant materials and 0.50 ± 0.58 for the un-
treated implant materials. The p value was 0.80, which
means that our result is not statistically significant. In
the long-term experiment, the Ta-treated implant mater-
ial had more newly formed bone (1.40 ± 0.89) compared
with the untreated implant material (1.33 ± 1.15). How-
ever, the result is not statically significant (p value = 0.9)
(Table 3).
Soft tissue thickness was expressed as micrometers
and reported as the mean ± SD. In the short-term ex-
periment, the thickness in the Ta-treated implant was
95 ± 71 μm, while in the untreated group, the thickness
was 111 ± 70 μm. The result was better for the Ta-
treated group, but the result was not statistically signifi-
cant (p value = 0.6). In the long-term study, the thickness
in the Ta-treated implant was 38 ± 17 μm, while in the
untreated group, the thickness was 70 ± 63 μm. Again,
the result was better for the Ta-treated group. However,
the result was not statistically significant (p value = 0.7).
New bone formation in the ePTFE implant material
showed better results for the Ta-treated implant.
However, there was no statistical significance observed
in either the short-term (p value = 0.6) or long-term
(p value = 0.6) studies.
Discussion
Surface treatment of facial implant materials using tanta-
lum (Ta) is considered a promising surface modification
technique. Tantalum surface treatment has attracted sig-
nificant interest because of the ability of tantalum to be
used as a surface treatment material via cold spray ion
implantation techniques. Cold spray has several advan-
tages over other surface treatment techniques. Specific-
ally, it results in little or no oxidation during material
buildup and it produces a dense coating. The process
can provide a relatively high deposition efficiency, and
the process is conducted in a cold environment, which
minimizes any deleterious effects on the treated material.
These characteristics explain the current popularity of
tantalum surface treatment [12]. Moreover, tantalum it-
self as a metal has great biological features. These
unique characteristics come from its ability to form a
self-passivating surface oxide layer. This external coating
layer leads to the formation of a bone-like apatite coat-
ing in vivo and affords excellent bone and fibrous in-
growth properties, allowing for rapid and substantial
bone and soft tissue attachment [13].
Many studies have used surface modification to
enhance the biocompatibility of medical devices (drug-
eluting stents, artificial organs, biosensors, catheters,
scaffolds for tissue engineering, heart valves, facial aug-
mentation materials, etc.). In orthopedics, tantalum
surface treatment is considered a promising surface
modification technique. It shows a good effect on cell
viability and differentiation. In clinical applications, tan-
talum has been used as a coating material and has been
shown to promote bone ingrowth [14]. Several studies
have suggested that tantalum surface treatment has the
ability to improve the surface mechanical properties and
osteogenic activity of orthopedic devices.
However, there are no studies on Ta-treated facial ma-
terials [5].
In this study, two commonly used facial implant mate-
rials (silicone and ePTFE) were treated using Ta ion im-
plantation. Silicone is frequently used to augment facial
Table 2 Histological evaluation of silicone implants
Soft tissue thickness New bone formation
Mean ± SD p value Mean ± SD p value
Ta-treated Untreated Ta-treated Untreated
4
weeks
73 ± 34 92 ± 43 0.7 0.00 0.00 –
8
weeks





Table 3 Soft tissue thickness in the ePTFE implant materials
Soft tissue thickness New bone formation
Mean ± SD p value Mean ± SD p value
Ta-treated Non-treated Ta-treated Non-treated
2 weeks 95 ± 71 111 ± 70 0.6 0.60 ± 0.55 0.50 ± 0.58 0.8
4 weeks 38 ± 17 70 ± 63 0.7 1.40 ± 0.89 1.33 ± 1.15 0.9
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defects. Although it is pliable and easily shaped, it still
has some disadvantages that lead to facial implant fail-
ure, such as implant displacement and the possibility of
infection. Gore-Tex is a trade name of expanded poly-
tetrafluoroethylene (ePTFE). It is safe to use long-term
with very rare instances of rejection. Furthermore,
ePTFE may be used as a guide membrane. However, a
disadvantage of this material is its tendency to fold on it-
self, which leads to infection [15]. Despite the improve-
ments in facial augmentation techniques, failures and
complications still occur [16].
In this experiment, using an in vitro study and optical
density measurements, the results of fibroblast cell via-
bility for the Ta-treated silicone (0.060 ± 0.013) implant
compared with the untreated implant (0.054 ± 0.008)
were found to be statistically insignificant (p value 0.4).
In addition, a statistically insignificant result was ob-
served for the ePTFE implant materials. Regardless of
whether the result is or is not statistically significant, it
is a promising result because it proves that tantalum is
not harmful to cells.
In this study, osteoblast viability assays were con-
ducted as well. Neither the Ta-treated silicone implant
material nor the Ta-treated ePTFE implant material was
significantly better than the corresponding control
groups. However, the mean osteoblast OD value of Ta-
treated implant materials (silicone 0.06, ePTFE 0.09) was
better than the mean OD values of the corresponding
untreated implant material (silicone 0.05, ePTFE 0.06).
However, in general, the result of the Ta-treated mater-
ial (silicone and ePTFE) was better than that of the un-
treated implant material. According to a previous result,
there was no negative effect on cell viability when using
tantalum as a coating material. Researchers have deter-
mined that the surface topography of an implanted ma-
terial is important for morphogenesis. In addition,
surface topography affects the biological behavior of cul-
tured cells, such as cell viability and differentiation [17].
In the absence of a foreign body, tissue trauma triggers
a series of events that comprise wound healing, i.e., in-
flammation, viability, and remodeling. The presence of a
foreign body interferes with the natural biological re-
sponse and disrupts the healing process. As a result, we
observe a foreign body reaction. The most common
histological signs of a foreign body reaction are as fol-
lows: an increase in macrophages and gain cell forma-
tion, an increase in fibroblast activity, and fibrous
encapsulation of the foreign body [18]. In our study,
during the daily postoperative period, zero rats showed
signs or symptoms of an allergic reaction (e.g., weight
loss, delayed wound healing, implant loss, dehiscence, or
any other signs).
During histological examination, macrophages and
giant cells were observed in the short-term experiments.
However, these histological findings were absent in the
long-term experiments. These features are a normal
body reaction after a wound or a cut [19]. During heal-
ing and the inflammatory phase, the migration of blood
cells (e.g., phagocytic neutrophils and macrophages) to
the wound site is a healthy physiological behavior [20].
Moreover, macrophages were not associated with any
other clinical finding. This means that these findings
were just a normal response to the surgical intervention.
Capsule contracture is considered to be an inevitable
complication of using silicone implants [21]. In this
study, the soft tissue filling the gap between the implant
and the underlying bone was measured. A decreased
thickness means less soft tissue deposition and more
completability. In addition, the amount of fibrous tissue
in a small layer of soft tissue will be less than the
amount of fibrous tissue in a thick soft tissue layer. With
no statistical significance, the soft tissue thickness in Ta-
treated implant materials was lower than that in the
control groups (untreated implant materials). Although
the result is not biostatistically strong, we can assume
that Ta treatment prevents fibrous capsule formation. It
is possible that this advantage is due to the implant’s
hydrophilic nature, which was acquired after Ta
treatment.
In this study, the soft tissue thickness in the 4-week
ePTFE implant material study was lower than that in the
2-week implants. This means that not all soft tissue is
due to a fibrotic band. Thus, a long-term experimental
study is recommended to verify whether we can achieve
definitive results regarding the soft tissue thickness
change after tantalum treatment. In the case of the sili-
cone implant material, even though the soft tissue thick-
ness of the Ta-treated group (73 ± 34) was better than
that of the untreated group (92 ± 43) after 4 weeks of ob-
servation, the 8-week observation result was not better
than that of the 4-week study.
Conclusion
Tantalum surface treatment using ion implantation on
silicone and ePTFE facial implant materials showed the
possibility of reducing soft tissue intervention between
the calvarium and the implant, which results in the im-
plant being more stable on the bone surface. Although
statistically significant improvement was observed only
for fibroblast viability on the Ta-treated implant, tanta-
lum treatment revealed a tendency toward improving
the biohistological response of silicone and ePTFE facial
implants. Conclusively, tantalum treatment is beneficial
and has the potential for clinical applications.
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